Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP2 | O95551 | 16/20 | 0.39 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | CDC7 | O00311 | 1/20 | 0.34 |
| ▸ | CDK2 | P24941 | 1/20 | 0.34 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.34 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21264550 | 0.89 | ACSS2 (0.36) | TDP2PLA2G10PLA2G2ACDC7CDK2 | |
| SCHEMBL21264776 | 0.87 | ALDH1A1 (0.38) | PLA2G10 | |
| SCHEMBL21264831 | 0.86 | ALDH1A1 (0.37) | PLA2G10 | |
| SCHEMBL21264480 | 0.78 | RPS6KB1 (0.38) | TDP2PLA2G10PLA2G2ARPS6KB1ACSS2 | |
| SCHEMBL21264692 | 0.78 | MAPK1 (0.33) | — | |
| SCHEMBL21264830 | 0.77 | ALDH1A1 (0.35) | PLA2G10 | |
| SCHEMBL21264646 | 0.77 | ALDH1A1 (0.40) | — | |
| SCHEMBL21264551 | 0.76 | CA1 (0.35) | TDP2PLA2G10PLA2G2ACDC7CDK2 | |
| SCHEMBL21264787 | 0.74 | ALDH1A1 (0.35) | PLA2G10 | |
| SCHEMBL21264786 | 0.74 | ALDH1A1 (0.39) | PLA2G10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190252623-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190252623-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ZYX, NSD3, NES | TDP2 4447/4885PLA2G10 3999/4885PLA2G2A 4356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.